« Back to Record
Citation APA

Chumsri, S., Li, Z., Serie, D. J., Norton, N., Mashadi-Hossein, A., Tenner, K., Brauer, H. A., Warren, S., Danaher, P., Colon-Otero, G., Partridge, A. H., Carey, L. A., Hilbers, F., Van Dooren, V., Holmes, E., Di Cosimo, S., Werner, O., Huober, J. B., Dueck, A. C., Sotiriou, C., Saura, C., Moreno-Aspitia, A., Knutson, K. L., Perez, E. A., & Thompson, E. A. (2022). Adaptive immune signature in HER2-positive breast cancer in NCCTG (Alliance) N9831 and NeoALTTO trials. NPJ breast cancer, 8(1), 68. doi:10.1038/s41523-022-00430-0


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/353890

Chumsri, S., Li, Z., Serie, D. J., Norton, N., Mashadi-Hossein, A., Tenner, K., Brauer, H. A., Warren, S., Danaher, P., Colon-Otero, G., Partridge, A. H., Carey, L. A., Hilbers, F., Van Dooren, V., Holmes, E., Di Cosimo, S., Werner, O., Huober, J. B., Dueck, A. C., Sotiriou, C., Saura, C., Moreno-Aspitia, A., Knutson, K. L., Perez, E. A., & Thompson, E. A. (2022). Adaptive immune signature in HER2-positive breast cancer in NCCTG (Alliance) N9831 and NeoALTTO trials. NPJ breast cancer, 8(1), 68. doi:10.1038/s41523-022-00430-0